This document provides an overview of stability studies, including the basic concepts, objectives, factors affecting stability, types of stability studies, ICH guidelines, climatic zones, steps for stability testing, and a reference. It defines stability as a drug substance or product retaining its properties and characteristics within specifications for a given time period. The objectives of stability testing are to determine shelf life and storage conditions, ensure formulation and packaging adequacy, understand quality variations over time, and prevent recalls. ICH guidelines cover testing requirements. Studies include long-term, accelerated, and intermediate testing under various climatic zone storage conditions.
Stability Testing During Product DevelopmentAl Riyad Hasan
Stability Testing During Product Development:
Practical conduct of stability testing
Presentation and recording of results
Stability data handling and estimation of shelf life
Package Labelling
Stability Testing During Product DevelopmentAl Riyad Hasan
Stability Testing During Product Development:
Practical conduct of stability testing
Presentation and recording of results
Stability data handling and estimation of shelf life
Package Labelling
ICH guidelines for stability studies of different formulation and active pharmaceuticals.
physical, chemical, microbial, toxicological therapeutic stability studies.
accelerated and intermediate, long term stability studies
by following the stability studies we can predict the expiry period and half life of product and avoid the toxic effect of the unstable product
ICH Guideline Stability Testing of New Drug Substances and Product Q1A(R2).pptxTrishala Bhatt
This presentation outlines the ICH Guideline for Stability Testing of New Drug Substances and Products, Q1A(R2). It serves as a comprehensive framework for ensuring the stability of new pharmaceuticals, with a focus on the requirements for registration applications within the EC, Japan, and the United States. The guideline emphasizes a balance between a standardized approach and the flexibility to adapt to specific scientific considerations and characteristics of the materials under evaluation.
Quality Safety Efficacy Multidisciplinary (Q S E M)
ICH Q1 Stability
Case toxicity of ethylene glycol and diethylene glycol in cough syrup.
accelerated stability studies
constant interval method
Toxic effects of heavy metals : Lead and Arsenicsanjana502982
Heavy metals are naturally occuring metallic chemical elements that have relatively high density, and are toxic at even low concentrations. All toxic metals are termed as heavy metals irrespective of their atomic mass and density, eg. arsenic, lead, mercury, cadmium, thallium, chromium, etc.
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...Wasswaderrick3
In this book, we use conservation of energy techniques on a fluid element to derive the Modified Bernoulli equation of flow with viscous or friction effects. We derive the general equation of flow/ velocity and then from this we derive the Pouiselle flow equation, the transition flow equation and the turbulent flow equation. In the situations where there are no viscous effects , the equation reduces to the Bernoulli equation. From experimental results, we are able to include other terms in the Bernoulli equation. We also look at cases where pressure gradients exist. We use the Modified Bernoulli equation to derive equations of flow rate for pipes of different cross sectional areas connected together. We also extend our techniques of energy conservation to a sphere falling in a viscous medium under the effect of gravity. We demonstrate Stokes equation of terminal velocity and turbulent flow equation. We look at a way of calculating the time taken for a body to fall in a viscous medium. We also look at the general equation of terminal velocity.
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxMAGOTI ERNEST
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Nucleophilic Addition of carbonyl compounds.pptxSSR02
Nucleophilic addition is the most important reaction of carbonyls. Not just aldehydes and ketones, but also carboxylic acid derivatives in general.
Carbonyls undergo addition reactions with a large range of nucleophiles.
Comparing the relative basicity of the nucleophile and the product is extremely helpful in determining how reversible the addition reaction is. Reactions with Grignards and hydrides are irreversible. Reactions with weak bases like halides and carboxylates generally don’t happen.
Electronic effects (inductive effects, electron donation) have a large impact on reactivity.
Large groups adjacent to the carbonyl will slow the rate of reaction.
Neutral nucleophiles can also add to carbonyls, although their additions are generally slower and more reversible. Acid catalysis is sometimes employed to increase the rate of addition.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Sachin stability and ich
1. Seminar on
Basic concept and objective of
Stability studies
PRESENTED BY:
Sachin. S .Bhagat
M.pharm (pharmaceutics)
Roll no :13
GUIDED BY-
Dr.D.V Derle
(principal)
MVP Samaj’s College Of Pharmacy, Nashik.
.
2. Contents.
• Introduction
• Factors affecting stability
• Types of stability
• Objective of stability
• Types of stability study
• ICH Guideline of stability study
• Climatic zone
• Steps of stability testing
• Reference
3. Introduction :
• Drug stability refers to capacity of drug substance or product to
remain within specification of identity, strength, quality and purity in
specific period of time
• Stability is officially define as time lapse during which the drug
product retain the same properties and characteristics that it
possessed at time of manufacture
• The stability of a product is expressed as the expiry period or
technically as shelf life
4. Shelf life.
• It is defined as the time required for the concentration of
drug/reactant to reduced to 90% of its initial concentration
• It represent as t90
• Unit : time/sec
• Formula : t90 =(a-0.9a)/k0
Where , a= initial concentration
k= specific rate constant for zero order reaction
5. Factors affecting Drug stability:
Primary factors:
• pH
• Temperature
• Moisture
• Humidity
• Light
• Container and closure
• Storage
7. Types of stability
• Therapeutical stability : therapeutic activity must be unchanged
• Chemical stability : chemical must be in pure form
• Microbiological stability : resistance to microbial growth
• Toxicological stability : no significant change
• Physical stability :appearance, palatability ,uniformity & suspend
ability
8. what happen due to instability:
1)increase in concentration of API:
for some product ,loss of vehicle can result in an increase in
concentration of active drug.
e.g. : lidocaine gel - perfusion bag sometime allow solvant to
evaporate so product within bag show an increase in concentration.
2)loss of content uniformity :
Suspension are the drug delivery system most likely to show content
uniformity as a function of time and for stability of such product
sedimentation volume and ease of redispersion should determine .
3)decline microbiological status :
Microbiological status of pharmaceutical can decline with time
prevention: drug assay for bioburden at time of manufacture, within
limit, and when tested after say 6 month storage exceed the maximum
permitted limits
9. 4) formation of toxic degradation product :
If drug degrade to molecular species that is toxic ,there must be special attention
given to the quantity of such product e.g conversion of p-amino salicylic acid to
p- amino phenol
Objective of stability testing :
1)concern for patient welfare :
primary reason for stability testing should be our concern for the well-being of
patient who will use our product
2) To protect the reputation of the producer:
The most important reason for conducting a stability testing program is to
assure ourselves the our product will indeed retain fitness for the use with respect
to all functionally relevant for along as they are on the market
10. 3)To check shelf life & storage condition & labelling specification :
By carrying out stability testing we can find out the shelf life and expiry
date. We can have information of best storage condition at which drug will
contain its stability for long time
If their is specification we can write on label
4) Adequate formulation &container closure system:
We can have idea about the formulation which will be more stable .and if during
stability testing we find any specification of container
E.g : menadione injection packed in amber color ampoule to protect from photo
degradation
5)How quality of drug substance or product varies with time under
influence of various factor
6) degradation of product& and possible degradation pathway
11. 7) Prevent great loss by recalling the batch due to stability
8)loss and increase in concentration of API
9) providing evidence on how quality of drug substance or product
varies with time under the influence of various factors like temperature,
humidity and light
10) loss of pharmaceutical elegance and patient acceptability
12. Guidance and requirement for stability study covered in :
1) international conference on harmonization (ICH)
2) WHO guideline for stability testing
3) US-FDA guideline
4) SUPAC guideline scale-up and post approval changes
13. Types of stability studies :
1) accelerated stability testing
2) intermediate stability testing
3) long term testing
4)degradation testing
5) photo stability testing
14. ICH guideline for stability testing :
ICH GUIDELINE TITLE
Q1A Stability testing of new drug product and substance
Q1B
Stability testing : photo stability testing of new drug product and
substance
Q1C Stability testing for new dosage form
Q1D
Bracketing and matrixing designs for stability testing of drug
substance and product
Q1E Evaluation of stability data
Q1F
Stability data package for registration application in climatic zone III
and IV
15. Climatic zones :
ZONES CLIMATE Storage condition
ZONE I Temperate 21 C/45% RH
ZONE II
Subtropical and high
humid
25 C/60%RH
ZONE III Hot & dry 30 C/35%RH
ZONE IV Hot & humid 30C/70%RH
16. Steps of stability testing :
1) selection of batches
2) Testing frequency
3) Storage condition
4) Acceptance criteria
5) Evaluation
6) Labelling
17. SELECTION OF BATCHES:
1)Stability information from accelerated & long term stability should provided on batches
Of same formulation & dosage form in container and closure purpose of manufacture
2)stability data of 3 primary batches should provided
3) expected that at least first 2 batches of manufacture should be tested for long term stab
4)the composition ,batch size, batch no & manufacturing date should documented
18. TESTING FREQUENCY:
According to ICH
Stability testing Testing interval
Real time testing (Q1) 0,3,6,9,12,24 Month
Accelerated testing 0,3& 6 month
Intermediate 0,6,9& 12 month
• For accelerated testing ,FDA suggest : 0,2,4& 6month
WHO suggest :0,1,2,3&6 month
• FDA & WHO do not suggest for intermediate testing
19. Storage condition :
According to Q1A &Q1F
ZONE I &II Temperature RELATIVE HUMDITY Time
Long term study 25℃ +2 60% + 5 12 month
Intermediate study 30℃ + 2 65% + 5 6 month
Accelerated study 40℃+ 2 75% + 5 6 month
ZONE III &IV Temperature Relative humidity
Long term 30℃+2 65% +5
Accelerated 40℃+2 75% +5
20. Acceptance criteria :
Significant change for a drug substance is defined as failure to
meet its specification
1) A 5% potency loss from initial assay value of a batch
2) Any specified degrading exceeding its specification limit
3) The product exceeding the pH limit
4) Dissolution exceeding specification limit for 12 capsule or
tablet
5) Failure to meet specification for appearance and physical
properties (e.g , color ,phase separation , caking, hardness,
resuspendability
6) 5% loss in water from its initial value form packaged in semi
permeable container
21. Evaluation
1) tabulate and plot stability data on all attributes at all storage condition and
evaluate each attribute separately
2) No significant change at accelerated condition within six month
3) Long term data show little or no variability and little or no change over time
22. Labelling :
1)Use of term such as “ ambient condition ’ or “ room temperature” is
unacceptable
2) where applicable , specific requirement should be stated e.g.
“protect from sunlight” ,”protection from freezing” the use of
precautionary statement should not be substituted
3)normal storage condition have been defined by WHO as “store in dry
, well ventilated premises at temperature of 15 - 25 ℃ .
4) store in refrigeration , no freezing ( 2& 8 )
5) in deep freezer (-18. )
6) In freezer (-5 to 20 )
23. REERENCE :
1) Drug stability : principles and practices ,1st Edition, edited by Jens T.
Carstensen and C.T. Rhodes (Marcel Dekker Inc, New York ,1990)
2) Textbook of physical pharmacy by C.V.S Subrahmanyam published by
M.K jain for Vallabh prakashan 5th edition 2004
3)
http://pharmaquest.weebly.com/uploads/9/9/4/2/9942916/basic_concept
_of_stability_studies.pdf